Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol
    Unavailable
    Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol
    Unavailable
    Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol
    Ebook816 pages8 hours

    Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol examines the combined issues of PEGylation and viable biomaterials as alternatives. With a strong focus on polymeric biomaterials, the book first reviews the major issues associated with PEGylation and its use in vivo. Chapters then focus on alternative polymer systems for drug delivery systems. Finally, nanoparticles and future perspectives are examined. This book is a valuable resource for scientists and researchers in biomaterials, pharmaceuticals and nanotechnology, and all those who wish to broaden their knowledge in this field.

    • Provides a self-contained work for the field of biomaterials for drug delivery
    • Summarizes the current knowledge on PEGylation and strategies for bypassing it
    • Presents research on an important, though under-represented issue in biomaterials
    • Written by a world-class team of research scientists, engineers and clinicians
    LanguageEnglish
    PublisherElsevier Science
    Release dateFeb 1, 2018
    ISBN9780081017517
    Unavailable
    Engineering of Biomaterials for Drug Delivery Systems: Beyond Polyethylene Glycol

    Related to Engineering of Biomaterials for Drug Delivery Systems

    Related ebooks

    Technology & Engineering For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine

      Oct 2, 2018

      When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.

      4 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Opinion: Enough With The Me-too Drugs. New Treatments Should Be Worthy Of The People Who Invest Their Lives In Clinical Trials

      Sep 4, 2019

      Drug developers should should treat patients who volunteer for clinical trials the way they would treat their mothers or husbands or best friends — but often don't.

      3 min read

    • Article

      The Elusive Miracle Drug

      Jun 27, 2020

      The Elusive Miracle Drug
      4 min read

    • Article

      Chasing The Cure

      Oct 10, 2020

      Chasing The Cure
      6 min read

    • Article

      Dr. William Levine

      Jan 3, 2020

      Dr. William Levine
      5 min read

    • Article

      Probiotics Are Touted As Good For The Gut. They May Be Trouble For The Immune System

      Apr 2, 2019

      Some scientists worry probiotics aren’t as innocuous as they seem — and might be affecting the way other medicines work in the body.

      4 min read

    • Article

      Opinion: Real-world Data Can Help Make Better Drugs And Do It Faster

      May 2, 2018

      Relying solely on clinical trials to demonstrate the safety and effectiveness of new drugs can be risky. Real-world data can help.

      4 min read

    • Article

      Opinion: From Bench To Bedside, Biologics Require Excellence At Every Stage

      Feb 13, 2020

      Quality and trust go together. As an industry, biologic manufacturers must deliver on quality. Public trust of sophisticated biological products will follow.

      3 min read

    • Article

      Q & A

      Nov 27, 2021

      With the COVID19 pandemic exerting enormous pressure on the healthcare infrastructure, the sector finds itself under the compulsion to step up. In this interview Dr. G.V. Sampath, Chairman, Naruvi Hospitals, Vellore addresses how India can make optim

      2 min read

    • Article

      Failing The Test

      May 2, 2020

      Failing The Test
      8 min read

    • Article

      Upfront

      Apr 1, 2024

      Give your kids plenty of broccoli sprouts-they'll thank you later, or at least their guts will. Eating sprouts and other cruciferous vegetables may reduce the risk of IBD (inflammatory bowel disease), colitis and Crohn's disease. Broccoli sprouts con

      11 min read

    • Article

      It’s Time for EPA to Regulate Chemicals by Class

      Apr 21, 2023

      Enacting strong regulations on chemicals by class, rather than individually, can help protect people and the environment.

      5 min read

    • Article

      Diagnosing The Cure

      Jul 23, 2018

      Diagnosing The Cure
      5 min read

    • Article

      Detection Gaps

      Apr 18, 2020

      Detection Gaps
      7 min read

    • Article

      Opinion: A Quantum Of Innovation And The Incentives To Match

      Mar 7, 2019

      Modest tweaks to drugs, what some dismiss as "merely incremental," can represent real and compelling advances for patients and offer great value over time.

      9 min read

    Related categories

    Reviews for Engineering of Biomaterials for Drug Delivery Systems

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words